# Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer

> **NCT03096093** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Cancer Vaccines Limited** · enrollment: 34 (estimated)

## Conditions studied

- Cancer
- Neoplasms

## Interventions

- **BIOLOGICAL:** ACIT-1

## Key facts

- **NCT ID:** NCT03096093
- **Lead sponsor:** Cancer Vaccines Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-04-25
- **Primary completion:** 2026-12
- **Final completion:** 2027-07
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03096093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03096093, "Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03096093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*